No single parasite has been definitively proven to cause diabetes in humans the way, say, a virus can trigger type 1 diabetes. But the relationship between parasites and diabetes is far more tangled than that simple statement suggests. One organism, Toxoplasma gondii, shows a consistent statistical link with higher diabetes risk, roughly doubling the odds in some studies. Meanwhile, a whole class of parasites, the helminths (parasitic worms), appear to do the opposite, potentially protecting against both type 1 and type 2 diabetes through their effects on the immune system. And complicating things further, diabetes itself weakens immunity in ways that make parasitic infections more likely, creating a chicken-and-egg problem researchers are still sorting out.
Toxoplasma Gondii and Type 2 Diabetes
Toxoplasma gondii is a single-celled parasite best known for its association with cats. Most people who carry it have no obvious symptoms, but the parasite persists in the body for life, forming dormant cysts in tissues including the brain and muscle. Several studies have now linked chronic T. gondii infection with a higher risk of type 2 diabetes. A systematic review and meta-analysis of human case-control studies found that about 48% of people with type 2 diabetes tested positive for T. gondii, compared with roughly 26% of healthy controls. The pooled odds ratio was 2.32, meaning T. gondii-positive individuals were more than twice as likely to have type 2 diabetes as those without the infection.1Bulletin of the National Research Centre. The association between Toxoplasma gondii and type 2 diabetes mellitus: a systematic review and meta-analysis of human case-control studies
More recent work has confirmed this pattern. A case-control study focused on women found that those with chronic toxoplasmosis were about 2.3 times more likely to have type 2 diabetes compared with uninfected women.2PubMed Central. The Possible Association Between Chronic Toxoplasmosis and Type-2 Diabetes Mellitus In Women: A Case-Control Study The consistency of this roughly twofold association across studies in different countries is striking, but it comes with a major caveat: association is not causation. People with poorly controlled diabetes have weakened immune defenses, which could make them more susceptible to acquiring and keeping T. gondii rather than the parasite driving the diabetes. Still, researchers have proposed plausible mechanisms through which the parasite could contribute. Chronic T. gondii infection drives low-grade inflammation and may interfere with insulin signaling, both of which are hallmarks of the pathway toward type 2 diabetes.
T. Gondii and Type 1 Diabetes
The story gets more complicated with type 1 diabetes, an autoimmune condition where the immune system destroys the insulin-producing cells in the pancreas. A systematic review pooling nine studies with over 2,600 participants found a pooled odds ratio of 2.45 for the association between T. gondii infection and type 1 diabetes, though this result was not statistically significant because the confidence interval was wide. When the researchers removed one outlying study, the odds ratio jumped to 3.38 and became significant.3PubMed Central. Association between Toxoplasma gondii Infection and Type-1 Diabetes Mellitus: A Systematic Review and Meta-Analysis That sensitivity to a single study’s inclusion tells you the evidence base is still thin. The association is suggestive, not settled.
Interestingly, animal research has shown a more paradoxical picture. In rodent models of type 1 diabetes, T. gondii infection has been observed to modulate the immune response in ways that could either accelerate or dampen autoimmune attack on the pancreas, depending on the experimental setup.4PubMed Central. Toxoplasma gondii modulates immune responses and mitigates type 1 diabetes progression in a streptozotocin-induced rat model This ambiguity is a recurring theme in parasitology and diabetes research: the immune changes a parasite triggers can cut both ways.
Helminths That May Protect Against Diabetes
If T. gondii sits on the “possibly harmful” side of the ledger, parasitic worms, collectively called helminths, sit squarely on the “possibly beneficial” side. This counterintuitive idea flows from the hygiene hypothesis: the notion that modern sanitation removed organisms our immune systems co-evolved with, and that their absence leaves the immune system prone to overreacting. In autoimmune conditions like type 1 diabetes, the immune system attacks the body’s own tissues. Helminth infections trigger a distinct immune profile that tends to suppress the kind of aggressive inflammatory responses involved in autoimmunity.5PubMed Central. Helminth infection and type 1 diabetes
The evidence comes from multiple directions. Populations with high rates of helminth infection tend to have lower rates of type 1 diabetes. In mouse models bred to develop autoimmune diabetes, helminth infections and helminth-derived molecules have repeatedly delayed or prevented disease onset.6PubMed. Helminth mediated modulation of Type 1 diabetes (T1D) Helminth-derived products, the molecules these worms secrete during infection, have shown enough anti-inflammatory promise that they are being explored in early-stage clinical trials for autoimmune diseases including type 1 diabetes, inflammatory bowel disease, and rheumatoid arthritis.7PubMed Central. Unraveling the Hygiene Hypothesis of helminthes and autoimmunity: origins, pathophysiology, and clinical applications
This protective effect is not limited to type 1 diabetes. Research increasingly suggests that by dampening chronic low-grade inflammation and promoting insulin sensitivity, helminths and their secreted products could also help with type 2 diabetes.8PubMed Central. Anti-Inflammatory Effects of Helminth-Derived Products: Potential Applications and Challenges in Diabetes Mellitus Management The mechanism matters here: type 2 diabetes is driven in part by chronic inflammation in fat tissue, and helminths appear to push the immune system toward a state that quiets exactly that kind of inflammation.
Schistosomiasis and Lower Diabetes Risk
Schistosomes, the blood flukes responsible for schistosomiasis, offer one of the clearest examples. A large cross-sectional study in rural China compared people with a history of schistosome infection against those who had never been infected. The results were dramatic: people with prior schistosome infection had significantly lower fasting blood glucose, lower post-meal blood glucose, and lower insulin resistance. The prevalence of diabetes in the previously infected group was about 15%, versus about 25% in the uninfected controls. After adjusting for other factors, people with a history of schistosome infection had roughly half the odds of having diabetes and only about 40% the odds of having metabolic syndrome.9The Journal of Clinical Endocrinology & Metabolism. Association of Previous Schistosome Infection With Diabetes and Metabolic Syndrome: A Cross-Sectional Study in Rural China
Mouse experiments have fleshed out the picture. In a study where mice were given schistosome infections alongside experimentally induced type 1 diabetes, type 2 diabetes, or obesity, the infected animals showed improved blood glucose and lipid levels compared with their uninfected, diabetic counterparts. The schistosome infection also favorably affected insulin levels in obese mice.10PubMed Central. The interaction of Schistosoma mansoni infection with diabetes mellitus and obesity in mice Nobody is recommending schistosomiasis as a treatment for diabetes; the disease can cause serious organ damage. But these findings help explain why diabetes rates tend to rise when worm infections are eliminated from a population, and they point toward the specific molecular pathways that future drugs might target.
Experimental Hookworm Therapy
Perhaps the most provocative evidence comes from a clinical trial in which researchers deliberately infected people at risk for type 2 diabetes with hookworms. The trial tested two doses of hookworm larvae (20 larvae and 40 larvae) against a placebo in people who already had elevated insulin resistance. After 12 months, the group that received 20 hookworm larvae saw their median insulin resistance score drop significantly, from 3.0 at baseline to 1.8. The placebo group moved in the opposite direction, with insulin resistance climbing from 2.2 to 2.9 over the same period. At two years, the improvement in the hookworm group was still present.11PubMed Central. Effect of experimental hookworm infection on insulin resistance in people at risk of type 2 diabetes
This was a small trial, and the higher dose of 40 larvae showed a similar trend that did not reach statistical significance. But it remains one of the only controlled experiments in humans to directly test the idea that a living parasite infection can improve metabolic health. The researchers noted that the improvement tracked with the worms establishing a stable infection and the host immune system shifting toward the anti-inflammatory profile that helminth researchers have been describing for years.
When Deworming Raises Insulin Resistance
If helminth infections improve insulin sensitivity, what happens when you eliminate them? A cluster-randomized trial in Indonesia gave albendazole (a common deworming drug) or placebo to communities where helminth infections were common. At the overall community level, deworming had no detectable effect on insulin resistance. But among people who were confirmed to be carrying worms at the start of the study, albendazole treatment led to a significant increase in insulin resistance compared to placebo. The researchers suggested this might be partly explained by the dewormed individuals gaining weight and losing the immune changes (including elevated eosinophil counts) associated with active worm infection.12Clinical Infectious Diseases. Effect of Anthelmintic Treatment on Insulin Resistance: A Cluster-Randomized, Placebo-Controlled Trial in Indonesia
This finding carries real public-health implications. Mass deworming programs are widespread in tropical countries and deliver enormous benefits by reducing anemia, malnutrition, and school absenteeism in children. But these results hint that in adult populations with high rates of metabolic disease, removing helminths may have unintended metabolic consequences. It is early evidence, and deworming programs should not be curtailed on its basis, but it adds urgency to the search for helminth-derived drugs that could deliver the metabolic benefits without requiring an actual infection.
Blastocystis and the Gut Microbiome
Blastocystis is a microscopic gut organism so common that hundreds of millions of people carry it without knowing. Its role in health is genuinely unclear; for decades it was dismissed as harmless, then reclassified by some researchers as a pathogen, and more recently has been reframed again as possibly beneficial in many cases. In the context of diabetes, the picture is muddled. Studies have found Blastocystis somewhat more often in people with type 2 diabetes (about 25%) than in non-diabetic controls (about 18%), but the difference is modest and may reflect diabetes-related immune changes rather than Blastocystis contributing to the disease.13PubMed Central. Blastocystis subtypes in patients with diabetes mellitus from the Midwest region of Brazil
What makes Blastocystis interesting in this space is its relationship with gut bacteria. In both diabetic and non-diabetic individuals, carrying Blastocystis was linked to greater diversity in the gut microbiome, which is generally considered a marker of better gut health. At the same time, certain subtypes of Blastocystis (particularly subtype 7) appeared to be associated with increases in potentially harmful bacteria in people with diabetes.14Universiti Sains Islam Malaysia. Differentiation of Blastocystis Subtypes and Their Association with Gut Microbiota in Type 2 Diabetes Mellitus Patients And Non-Diabetic Individuals The emerging view is that Blastocystis is not one thing: different subtypes living in different hosts (diabetic versus healthy) have different effects. This makes broad claims about Blastocystis either causing or preventing diabetes premature.
Diabetes Makes You More Vulnerable to Parasites
Much of the confusion around the parasite-diabetes question stems from a relationship that runs in the other direction. Poorly controlled diabetes impairs immune function, particularly the white blood cell responses and gut defenses that keep parasites in check. A case-control study found intestinal parasites in 44% of diabetic patients versus 32% of non-diabetic controls. The most common parasites in the diabetic group were Blastocystis (29% of cases) and Cryptosporidium (12%), with a statistically significant difference for Microsporidia, an opportunistic organism that tends to cause disease mainly in immunocompromised people.15PubMed Central. Intestinal parasitic infections and associated risk factors in diabetic patients: a case-control study
This vulnerability matters practically. If you have diabetes, particularly if blood sugar is not well controlled, you face a higher risk of picking up intestinal parasites and of those infections becoming more severe. Gastrointestinal symptoms that might be shrugged off in a healthy person, persistent diarrhea, bloating, or unexplained weight loss, deserve more attention in someone with diabetes because an underlying parasitic infection is more likely.16Journal of Pure and Applied Microbiology. Prevalence of Intestinal Parasites among Diabetes Mellitus Patients in Tertiary Care Hospital The takeaway is that many studies finding “more parasites in diabetic patients” are documenting a consequence of diabetes rather than its cause.
Malaria and Blood Sugar Swings
Malaria deserves mention because it can cause dramatic blood sugar problems during active infection, though not diabetes in the chronic sense. Severe falciparum malaria, especially cerebral malaria, can trigger dangerous drops in blood sugar. In a study of patients with severe falciparum malaria, hypoglycemia occurred in 17 patients, often severely and repeatedly. Part of the problem was the malaria parasite itself driving up insulin levels, and part was the treatment: quinine, a standard antimalarial drug, stimulates insulin release. Plasma quinine and insulin levels were correlated during hypoglycemic episodes.17PubMed. Severe hypoglycemia and hyperinsulinemia in falciparum malaria
These episodes are acute and resolve when the infection is treated. There is no strong evidence that malaria causes permanent diabetes. But in areas where malaria is endemic and diabetes is rising, the blood sugar disruptions of acute malaria on top of existing prediabetes or diabetes can be life-threatening. Clinicians treating severe malaria monitor blood glucose closely for exactly this reason.
Leishmania and the Role of Immune Regulators
An exploratory study in mice genetically predisposed to type 1 diabetes examined what happened when these animals were infected with Leishmania amazonensis, a parasite transmitted by sandflies. In uninfected mice lacking a protein called osteopontin (a key immune regulator), diabetes developed much faster. But when those same mice were infected with the Leishmania parasite, diabetes was significantly delayed. Wild-type mice, meanwhile, showed a more complicated picture: infection appeared to delay diabetes early on but eventually led to higher cumulative rates over time.18PLOS ONE. Type 1 diabetes and parasite infection: An exploratory study in NOD mice
This kind of research is far from applicable to humans. You cannot extrapolate from genetically engineered mice infected with a specific Leishmania species to real-world diabetes risk. But the study illustrates a broader principle that keeps emerging: parasites modulate the immune system in ways that interact with autoimmune diabetes through multiple pathways. The specific outcome, whether diabetes is accelerated, delayed, or unaffected, depends on the parasite species, the dose, the host’s genetic background, and which immune pathways are already active. The field is nowhere near a simple “parasite X causes diabetes” conclusion.
Hydatid Cysts and the Pancreas
There is one scenario where a parasite can directly damage the pancreas, though it is rare. Echinococcus granulosus, the tapeworm that causes hydatid disease, can occasionally form cysts in the pancreas. A review of published cases found that complications of pancreatic hydatid cysts included pancreatitis, fistulas connecting the cyst to the bile ducts or pancreatic ducts, and portal hypertension.19PubMed Central. Hydatid cyst of the pancreas: Report of an undiagnosed case of pancreatic hydatid cyst and brief literature review Pancreatitis from a hydatid cyst can, in theory, damage enough pancreatic tissue to impair insulin production, leading to secondary diabetes. But this is an extraordinarily rare event. Pancreatic hydatid cysts account for a tiny fraction of all hydatid disease cases, and not all of them cause enough tissue destruction to affect blood sugar regulation. It is a medical curiosity rather than a meaningful pathway to diabetes for most people.
Why the Field Remains Unsettled
The fundamental challenge in untangling parasites and diabetes is that almost all the human evidence is observational. Case-control studies can tell you that people with diabetes are more likely to carry T. gondii, but they cannot tell you which came first. Populations free of helminths have more diabetes, but they also live in wealthier countries with different diets, activity levels, and genetic backgrounds. The handful of controlled experiments in humans, like the hookworm trial, are small and need replication. Animal models provide cleaner causal evidence but do not always translate to people.
Researchers studying helminth-derived molecules as potential drugs face a particular puzzle. The anti-inflammatory molecules worms produce during infection are complex mixtures of proteins and small molecules. Isolating the specific components responsible for improved insulin sensitivity, then manufacturing them as stable pharmaceuticals, is a long road. Early reviews describe this as one of the most promising areas in metabolic research, but clinical applications are likely years away.8PubMed Central. Anti-Inflammatory Effects of Helminth-Derived Products: Potential Applications and Challenges in Diabetes Mellitus Management For now, the clearest practical message is this: if you have diabetes, you are more vulnerable to parasitic infections and should take standard precautions around food and water safety, especially when traveling. And if you are reading about parasites and diabetes hoping for a simple answer, the biology is not cooperating.